ArticleBMC public health2025
Model-based estimation of the generalized impact fraction (GIF) and population attributable fraction (PAF) for interventions targeting risk factors affecting the five-year risk of diabetic retinopathy.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDiabetic Retinopathy (DR) is a microvascular complication of diabetes mellitus. Health policymakers are interested in studying the impact of interventions on reducing new cases of DR. The study aimed to calculate the generalized impact fraction (GIF) and population attributable fraction (PAF) of interventions targeting three risk factors on the five-year risk of DR.
methodsA retrospective cohort study was conducted among 1,742 patients with diabetes who completed their baseline assessment between 2015 and 2017. Follow-up studies were carried out during visits from 2020 to 2022, aiming to determine the five-year risk of DR. To estimate the PAF and GIF in different scenarios, a parametric G. formula was utilized.
resultsIn this study, all patients had type 2 diabetes, and the five-year risk of developing diabetic retinopathy (DR) was 16.1% (95% CI: 14.4-18.0). Lowering HbA1c to below 7% would be expected to prevent 35.07% (95% CI: 34.7-36.2) of DR cases. A reduction of 30% in patients with HbA1c levels above 7% corresponds to a GIF of 10.3% (95% CI: 9.9-10.7). Similarly, normalizing blood pressure levels resulted in a PAF of 22.1% (95% CI: 21.8-22.6). A 25% decrease in prevalence above 130/80 mmHg was associated with a GIF for DR of 5.3% (95% CI: 5.1-5.4). Reducing LDL cholesterol levels to less than 100 mg/dl had a lower impact, with a PAF of 1.9% (95% CI: 1.3-2.3). A 20% reduction in prevalence above this level corresponded to a GIF of 0.3% (95% CI: 0.2-0.5).
conclusionReducing HbA1c and blood pressure by 20-30% would be expected to prevent the five-year risk of DR by 15.5% (95% CI: 15.3-15.9). These levels of decrease are achievable and conceivable to policymakers, which can encourage them to implement a program. This could be a Policy-making approach to prevent DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.